|5. In adults with active AS despite treatment with NSAIDs, we conditionally recommend treatment with TNFi over treatment with tofacitinib.|Very low|60|
|6. In adults with active AS despite treatment with NSAIDs, we strongly recommend treatment with TNFi over no treatment with TNFi.|High|6|
|7. We do not recommend any particular TNFi as the preferred choice.|Moderate|5|